​

Funding Round

Series A - ExpressCells

Series A - ExpressCells

Investment Firm

Overview

ExpressCells creates custom cell lines for biological research and drug discovery.

Announced Date

Jul 01, 2019

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Rowan University

Rowan University

No designation

Keiretsu Forum Mid Atlantic

Keiretsu Forum Mid Atlantic

Keiretsu Forum Mid Atlantic is a early_stage_venture and venture firm.

Participant Investors

3

Investor Name
Participant InvestorKeiretsu Forum Mid Atlantic
Participant InvestorRowan University
Participant InvestorRobin Hood Ventures

Round Details and Background

ExpressCells raised $1200000 on 2019-07-01 in Series A

ExpressCells creates custom cell lines for biological research and drug discovery.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 01, 2019
Series A - ExpressCells
3-1.2M
Oct 23, 2020
Venture Round - ExpressCells
4-590.5K

Recent Activity

There is no recent news or activity for this profile.